Ephrin (Eph) receptor and downstream signaling pathways: a promising potential targeted therapy for COVID‑19 and associated cancers and diseases

Hum Cell. 2022 May;35(3):952-954. doi: 10.1007/s13577-022-00697-2. Epub 2022 Apr 4.

Authors

Hamidreza Zalpoor^{1

2

3}, Abdullatif Akbari^{2

3}, Mohsen Nabi-Afjadi⁴

Affiliations

¹ American Association of Kidney Patients, Tampa, FL, USA.
² Shiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
³ Network of Immunity in Infection, Malignancy & Autoimmunity (NIIMA), Universal Scientific Education & Research Network (USERN), Tehran, Iran.
⁴ Department of Biochemistry, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran. mohsennabi66@gmail.com.

No abstract available

Keywords: COVID-19; Cancer; Eph receptors; Ephrins; Human host cell; SARS-CoV-2; Signaling pathways.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Ephrins
Humans
Neoplasms* / therapy
Receptor, EphA1 / metabolism*
Receptors, Eph Family / metabolism
Signal Transduction / genetics

Substances

Ephrins
Receptor, EphA1
Receptors, Eph Family